drug

granisetron

1 story · latest Jul 1, 2026

Status: FDA approved Sep 2008 · NDA022198, NDA022445
Brands: Sancuso, Sustol

Relationships

Developed by Cumberland Pharmaceuticals Inc

Timeline

Cumberland closes $100 million asset sale to Apotex, keeps rare disease pipeline

Jul 1Regulatory decisionCumberland Pharmaceuticals Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.